Viewing Study NCT06317805


Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2026-01-06 @ 2:42 PM
Study NCT ID: NCT06317805
Status: RECRUITING
Last Update Posted: 2024-03-19
First Post: 2024-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Sponsor: AOP Orphan Pharmaceuticals AG
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-12-06
Start Date Type: ACTUAL
Primary Completion Date: 2027-06
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-06-30
Completion Date Type: ESTIMATED
First Submit Date: 2024-02-20
First Submit QC Date: None
Study First Post Date: 2024-03-19
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-03-12
Last Update Post Date: 2024-03-19
Last Update Post Date Type: ACTUAL